Market Cap: $14.64M
AI
Allarity Therapeutics, Inc.
ALLR
NASDAQ (NASDAQ Global Market)USD
Market Cap: $14.64M
Allarity Therapeutics Faces Regulatory Scrutiny Following SEC Wells Notice Allarity Therapeutics, Inc. is currently under investigation by The Schall Law Firm, which represents investors concerned abo…
Regulatory Scrutiny Intensifies for Allarity Therapeutics Amid SEC Investigation Allarity Therapeutics, Inc. faces significant scrutiny following the receipt of a "Wells Notice" from the U.S. Securiti…
Investigation into Allarity Therapeutics Raises Concerns Over Regulatory Compliance Allarity Therapeutics, Inc., a biopharmaceutical company focused on developing cancer therapies, finds itself under…
Allarity Therapeutics Faces Legal Scrutiny Over SEC Violations Allarity Therapeutics, Inc. is currently under investigation by the Schall Law Firm for potential violations of securities laws. This inq…
Allarity Therapeutics Faces Legal Scrutiny Over SEC Inquiry Allarity Therapeutics, Inc. is currently under investigation by the Schall Law Firm, which is examining claims regarding potential violation…
### Allarity Therapeutics Faces Class Action Lawsuit Over Alleged Misrepresentation Allarity Therapeutics, Inc. is currently embroiled in a class action lawsuit filed by the Schall Law Firm, alleging…
Allarity Therapeutics Faces Class Action Lawsuit Over Misleading Drug Statements Allarity Therapeutics, Inc. is currently embroiled in a class action lawsuit initiated by the Schall Law Firm, which al…
Allarity Therapeutics Faces Legal Scrutiny Over Dovitinib Claims Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, finds itself embroiled in a class action lawsuit that raises s…
Allarity Therapeutics Faces Class Action Lawsuit Over Regulatory Misconduct Allarity Therapeutics, Inc. is currently embroiled in a class action lawsuit that raises serious allegations regarding the c…
### Allarity Therapeutics Faces Class Action Lawsuit Over Alleged Misleading Statements Allarity Therapeutics, Inc. (NASDAQ: ALLR) is currently embroiled in a major legal challenge as multiple law fir…
Allarity Therapeutics Faces Class Action Lawsuit Amid Allegations of Misleading Statements Allarity Therapeutics, Inc. is currently embroiled in a class action lawsuit initiated by the Schall Law Firm…
Allarity Therapeutics Faces Legal Scrutiny Over Drug Candidate Misrepresentations Allarity Therapeutics, Inc. finds itself under legal scrutiny as a class action lawsuit unfolds, centering on allegati…
Allarity Therapeutics Faces Class Action Over Regulatory Misconduct Allegations Allarity Therapeutics, Inc. finds itself at the center of a potential securities fraud class action lawsuit, as Glancy P…
Allarity Therapeutics Faces Securities Fraud Allegations Amidst Regulatory Scrutiny Allarity Therapeutics, Inc. finds itself at the center of a securities fraud class action lawsuit led by Glancy Pron…
Allarity Therapeutics Faces Class Action Lawsuit Over Misleading Statements Allarity Therapeutics, Inc. is currently embroiled in a class action lawsuit initiated by the Schall Law Firm, stemming from…
Class Action Lawsuit Highlights Concerns Over Allarity Therapeutics' Dovitinib Rosen Law Firm, a leading global investor rights law firm, announces a class action reminder for buyers of Allarity Thera…